


YAP-Inhibitors-Modulators-MCE.docx 免費(fèi)下載
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、 HYPERLINK https:/www.MedChemE/Targets/YAP.html YAPYes-associated proteinYAP (Yes-associated protein) is a transcription co-activator in the Hippo tumor suppressor pathway and controls cell growth, tissuehomeostasis and organ size. YAP is inhibited by the kinase Lats, which phosphorylates YAP to ind
2、uce its cytoplasmic localizationand proteasomal degradation. YAP induces gene expression by binding to the TEAD family transcription factors.The function of YAP in human cancer is complex and could be cell-type-dependent. For instance, YAP could function as a tumorsuppressor in some cell types, such
3、 as hematological cancers, by inducing apoptosis in response to DNA damage.www.MedChemE 1 HYPERLINK https:/www.MedChemE/Targets/YAP.html YAP HYPERLINK https:/www.MedChemE/Targets/YAP.html HYPERLINK https:/www.MedChemE/Targets/YAP.html Inhibitors, HYPERLINK https:/www.MedChemE/Targets/YAP.html HYPERL
4、INK https:/www.MedChemE/Targets/YAP.html Antagonists, HYPERLINK https:/www.MedChemE/Targets/YAP.html HYPERLINK https:/www.MedChemE/Targets/YAP.html Activators HYPERLINK https:/www.MedChemE/Targets/YAP.html HYPERLINK https:/www.MedChemE/Targets/YAP.html & HYPERLINK https:/www.MedChemE/Targets/YAP.htm
5、l HYPERLINK https:/www.MedChemE/Targets/YAP.html Modulators HYPERLINK https:/www.MedChemE/AICAR.html AICAR(Acadesine; AICA Riboside) Cat. No.: HY-13417 HYPERLINK https:/www.MedChemE/AICAR-phosphate.html AICAR HYPERLINK https:/www.MedChemE/AICAR-phosphate.html HYPERLINK https:/www.MedChemE/AICAR-phos
6、phate.html phosphate(Acadesine phosphate; AICA Riboside phosphate) Cat. No.: HY-13417AAICAR (Acadesine) is an adenosine analog and aAMPK activator. AICAR regulates the glucose andlipid metabolism, and inhibits proinflammatorycytokines and iNOS production. AICAR is also anautophagy, YAP and mitophagy
7、 inhibitor.AICAR phosphate (Acadesine phosphate) is anadenosine analog and a AMPK activator. AICARphosphate regulates the glucose and lipidmetabolism, and inhibits proinflammatory cytokinesand iNOS production. AICAR phosphate is also anautophagy, YAP and mitophagy inhibitor.Purity: 99.92%Clinical Da
8、ta: Phase 3Size: 50 mg, 100 mg, 200 mg, 500 mgPurity: 99.49%Clinical Data: Phase 3Size: 10 mM 1 mL, 50 mg, 100 mg, 200 mg, 500 mg HYPERLINK https:/www.MedChemE/cytochalasin-d.html Cytochalasin HYPERLINK https:/www.MedChemE/cytochalasin-d.html HYPERLINK https:/www.MedChemE/cytochalasin-d.html D(Zygos
9、porin A; NSC 209835) Cat. No.: HY-N6682 HYPERLINK https:/www.MedChemE/k-975.html K-975Cat. No.: HY-138565Cytochalasin D (Zygosporin A; NSC 209835) is apotent and cell-permeable inhibitor of actinpolymerization derived from fungus, inhibits theG-actincofilin interaction by binding to G-actin.K-975 is
10、 a potent, selective and orally activeTEAD inhibitor, with a strong inhibitory effectagainst protein-protein interactions betweenYAP1/TAZ and TEAD. K-975 covalently binds toCys359 located in the palmitate-binding pocket ofTEAD via an acrylamide structure.Purity: 99.75%Clinical Data: No Development R
11、eportedSize: 10 mM 1 mL, 1 mg, 5 mg, 10 mgPurity: 98.55%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/lats-in-1.html Lats-IN-1 HYPERLINK https:/www.MedChemE/lats-in-1.html HYPERLINK https:/www.MedChemE/ML-7-hydrochloride.html ML-7 HYPERLI
12、NK https:/www.MedChemE/ML-7-hydrochloride.html HYPERLINK https:/www.MedChemE/ML-7-hydrochloride.html hydrochlorideCat. No.: HY-138489 Cat. No.: HY-15417Lats-IN-1 is a potent and ATP-competitiveinhibitor of Lats1 and Lats2 kinases. Lats-IN-1promotes Yap-dependent proliferation inpostmitotic mammalian
13、 tissues.ML-7 hydrochloride is a naphthalene sulphonamidederivative, potently inhibits MLCK (IC =30050nM). ML-7 hydrochloride also inhibits YAP/TAZ.Purity: 99.98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 99.75%Clinical Data: No Development ReportedSize: 10
14、mM 1 mL, 10 mg, 50 mg HYPERLINK https:/www.MedChemE/myf-01-37.html MYF-01-37 HYPERLINK https:/www.MedChemE/myf-01-37.html HYPERLINK https:/www.MedChemE/py-60.html PY-60Cat. No.: HY-139603 Cat. No.: HY-141644MYF-01-37 is a covalent TEAD inhibitor targetingCys380. MYF-01-37 has a reversible inhibition
15、 onYAP/TEAD interaction.PY-60 is a robust and specific activator of YAPtranscriptional activity that targets annexin A2(ANXA2) with a K of 1.4 M. PY-60 directlydbinds to ANXA2 and antagonizes its normal cellularfunction of repressing YAP activity.Purity: 98.98%Clinical Data: No Development ReportedS
16、ize: 5 mg, 10 mg, 50 mg, 100 mgPurity: 98.63%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/super-tdu.html Super-TDU HYPERLINK https:/www.MedChemE/super-tdu.html HYPERLINK https:/www.MedChemE/super-tdu-1-31.html Super-TDU HYPER
17、LINK https:/www.MedChemE/super-tdu-1-31.html HYPERLINK https:/www.MedChemE/super-tdu-1-31.html (1-31)Cat. No.: HY-P1727 Cat. No.: HY-P1728Super-TDU is a specific YAP antagonist targetingYAP-TEADs interaction. Super-TDU suppresses tumorgrowth in gastric cancer mouse model.Super-TDU (1-31) is a peptid
18、e of Super-TDU, whichis an inhibitor of YAP-TEADs, shows potentanti-tumor activity.Purity: 98.85%Clinical Data: No Development ReportedSize: 10 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/
19、super-tdu-1-31-tfa.html Super-TDU HYPERLINK https:/www.MedChemE/super-tdu-1-31-tfa.html HYPERLINK https:/www.MedChemE/super-tdu-1-31-tfa.html (1-31) HYPERLINK https:/www.MedChemE/super-tdu-1-31-tfa.html HYPERLINK https:/www.MedChemE/super-tdu-1-31-tfa.html (TFA) HYPERLINK https:/www.MedChemE/super-t
20、du-1-31-tfa.html HYPERLINK https:/www.MedChemE/super-tdu-tfa.html Super-TDU HYPERLINK https:/www.MedChemE/super-tdu-tfa.html HYPERLINK https:/www.MedChemE/super-tdu-tfa.html TFACat. No.: HY-P1728A Cat. No.: HY-P1727ASuper-TDU (1-31) is a peptide of Super-TDU, whichis an inhibitor of YAP-TEADs, shows
21、 potentanti-tumor activity.Super-TDU TFA is a specific YAP antagonisttargeting YAP-TEADs interaction. Super-TDU TFAsuppresses tumor growth in gastric cancer mousemodel.Purity: 96.04%Clinical Data: No Development ReportedSize: 1 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPE
22、RLINK https:/www.MedChemE/ted-347.html TED-347Cat. No.: HY-125269 HYPERLINK https:/www.MedChemE/Verteporfin.html Verteporfin(CL 318952) Cat. No.: HY-B0146TED-347 is a potent, irreversible, covalent andallosteric inhibitor at YAP-TEAD protein-proteininteraction with an EC of 5.9 M for TEAD4Yap150prot
23、ein-protein interaction.Verteporfin (CL 318952) is a photosensitizer forphotodynamic therapy to eliminate the abnormalblood vessels in the eye associated withconditions such as age-related maculardegeneration. Verteporfin is a YAP inhibitorwhich disrupts YAP-TEAD interactions.Purity: 98.78%Clinical
24、Data: No Development ReportedSize: 10 mM 1 mL, 1 mg, 5 mg, 10 mg, 25 mg, 50 mgPurity: 99.58%Clinical Data: LaunchedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/vt103.html VT103 HYPERLINK https:/www.MedChemE/vt103.html HYPERLINK https:/www.MedChemE/vt107.html VT107Cat. N
25、o.: HY-134955 Cat. No.: HY-134957VT103, an analog of VT101, is an orally active andselective TEAD1 protein palmitoylation inhibitor.VT103 inhibits YAP/TAZ-TEAD promoted genetranscription, blocks TEAD auto-palmitoylation,and disrupts interaction between YAP/TAZ andTEAD.VT-107, as an analogous to VT10
26、4, is an orallyactive and potent pan-TEAD auto-palmitoylationinhibitor. VT-107 can be used for the research ofcancer.Purity: 99.21%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 99.98%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50
27、 mg, 100 mg HYPERLINK https:/www.MedChemE/yap-tead.html YAP-TEAD-IN-1 HYPERLINK https:/www.MedChemE/yap-tead.html HYPERLINK https:/www.MedChemE/yap-tead-tfa.html YAP-TEAD-IN-1 HYPERLINK https:/www.MedChemE/yap-tead-tfa.html HYPERLINK https:/www.MedChemE/yap-tead-tfa.html TFACat. No.: HY-P2244 Cat. No.: HY-P2244AYAP-TEAD-IN-1 is a potent and competitiveinhibitor of YAPTEAD interaction (IC =2550nM). YAP-TEAD-IN-1 is a 17mer pep
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 【正版授權(quán)】 ISO/IEC 29110-5-1-1:2025 EN Systems and software engineering - Life cycle profiles for very small entities (VSEs) - Part 5-1-1: Software engineering guidelines for the gener
- 【正版授權(quán)】 ISO/IEC 27035-4:2024 EN Information technology - Information security incident management - Part 4: Coordination
- 酒店設(shè)施改造與管理輸出合同
- 網(wǎng)絡(luò)安全評(píng)估及防護(hù)服務(wù)合同
- 掛靠房地產(chǎn)公司協(xié)議書
- 簡(jiǎn)易離婚協(xié)議書
- 技師勞動(dòng)合同
- 愛眼日學(xué)校活動(dòng)方案(3篇)
- 美容院會(huì)員卡轉(zhuǎn)讓合同
- 網(wǎng)絡(luò)直播活動(dòng)策劃方案
- 城市開放空間-課件
- 2025年春季學(xué)期學(xué)校德育工作計(jì)劃安排表(完整版)
- 《幼兒教育政策與法規(guī)》教案-單元4 幼兒園的保育和教育
- 電氣化基本知識(shí)-崗培教材編寫86課件講解
- 2024年廣東省公務(wù)員錄用考試《行測(cè)》試題及答案解析
- 人工智能需求文檔6篇
- 軸承專用中英文對(duì)照表 (完整版)
- 了解現(xiàn)代漢字字義的特點(diǎn)根據(jù)形旁的表義ppt課件
- 人教版小學(xué)數(shù)學(xué)四年級(jí)下冊(cè)教材分析ppt課件
- 嵩晟富氫水銷售方案ppt課件
- 藥物療法和過敏試驗(yàn)法護(hù)理學(xué)基礎(chǔ)
評(píng)論
0/150
提交評(píng)論